These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 35505032)
1. Evaluation of the Antitumor Immune Response Following Photofrin-Based PDT in Combination with the Epigenetic Agent 5-Aza-2'-Deoxycytidine. Wachowska M; Muchowicz A; Golab J Methods Mol Biol; 2022; 2451():559-567. PubMed ID: 35505032 [TBL] [Abstract][Full Text] [Related]
4. Antitumor effect of photodynamic therapy in mice using direct application of Photofrin dissolved in lidocaine jelly. Murakami H; Kohno E; Kohmura Y; Ozawa H; Ito H; Sugihara K; Horiuchi K; Hirano T; Kanayama N Photodermatol Photoimmunol Photomed; 2009 Oct; 25(5):259-63. PubMed ID: 19747245 [TBL] [Abstract][Full Text] [Related]
5. Photodynamic therapy induces an immune response against a bacterial pathogen. Huang YY; Tanaka M; Vecchio D; Garcia-Diaz M; Chang J; Morimoto Y; Hamblin MR Expert Rev Clin Immunol; 2012 Jul; 8(5):479-94. PubMed ID: 22882222 [TBL] [Abstract][Full Text] [Related]
6. Sustained activation of the extracellular signal-regulated kinase pathway protects cells from photofrin-mediated photodynamic therapy. Tong Z; Singh G; Rainbow AJ Cancer Res; 2002 Oct; 62(19):5528-35. PubMed ID: 12359764 [TBL] [Abstract][Full Text] [Related]
7. Combination of verteporfin-photodynamic therapy with 5-aza-2'-deoxycytidine enhances the anti-tumour immune response in triple negative breast cancer. Banerjee SM; Acedo P; El Sheikh S; Harati R; Meecham A; Williams NR; Gerard G; Keshtgar MRS; MacRobert AJ; Hamoudi R Front Immunol; 2023; 14():1188087. PubMed ID: 38022682 [TBL] [Abstract][Full Text] [Related]
8. Photofrin binds to procaspase-3 and mediates photodynamic treatment-triggered methionine oxidation and inactivation of procaspase-3. Hsieh YJ; Chien KY; Lin SY; Sabu S; Hsu RM; Chi LM; Lyu PC; Yu JS Cell Death Dis; 2012 Jul; 3(7):e347. PubMed ID: 22785533 [TBL] [Abstract][Full Text] [Related]
9. Treatment with the tumor necrosis factor-alpha-inducing drug 5,6-dimethylxanthenone-4-acetic acid enhances the antitumor activity of the photodynamic therapy of RIF-1 mouse tumors. Bellnier DA; Gollnick SO; Camacho SH; Greco WR; Cheney RT Cancer Res; 2003 Nov; 63(22):7584-90. PubMed ID: 14633671 [TBL] [Abstract][Full Text] [Related]
13. Increased tumour dihydroceramide production after Photofrin-PDT alone and improved tumour response after the combination with the ceramide analogue LCL29. Evidence from mouse squamous cell carcinomas. Separovic D; Bielawski J; Pierce JS; Merchant S; Tarca AL; Ogretmen B; Korbelik M Br J Cancer; 2009 Feb; 100(4):626-32. PubMed ID: 19223911 [TBL] [Abstract][Full Text] [Related]
14. Activation of the stress-activated JNK and p38 MAP kinases in human cells by Photofrin-mediated photodynamic therapy. Tong Z; Singh G; Valerie K; Rainbow AJ J Photochem Photobiol B; 2003 Oct; 71(1-3):77-85. PubMed ID: 14705642 [TBL] [Abstract][Full Text] [Related]
15. Subcellular localization of Photofrin determines the death phenotype of human epidermoid carcinoma A431 cells triggered by photodynamic therapy: when plasma membranes are the main targets. Hsieh YJ; Wu CC; Chang CJ; Yu JS J Cell Physiol; 2003 Mar; 194(3):363-75. PubMed ID: 12548556 [TBL] [Abstract][Full Text] [Related]
16. Photofrin based photodynamic therapy and miR-99a transfection inhibited FGFR3 and PI3K/Akt signaling mechanisms to control growth of human glioblastoma In vitro and in vivo. Chakrabarti M; Banik NL; Ray SK PLoS One; 2013; 8(2):e55652. PubMed ID: 23409016 [TBL] [Abstract][Full Text] [Related]
17. Identification of MAP kinase pathways involved in COX-2 expression following photofrin photodynamic therapy. Luna M; Ferrario A; Wong S; Gomer CJ Methods Mol Biol; 2010; 635():47-63. PubMed ID: 20552339 [TBL] [Abstract][Full Text] [Related]
18. Anti-tumor effect of PDT using Photofrin in a mouse angiosarcoma model. Jin I; Yuji M; Yoshinori N; Makoto K; Mikio M Arch Dermatol Res; 2008 Apr; 300(4):161-6. PubMed ID: 18080130 [TBL] [Abstract][Full Text] [Related]
19. The effect of ephrin-A1 on resistance to Photofrin-mediated photodynamic therapy in esophageal squamous cell carcinoma cells. Yang PW; Chiang TH; Hsieh CY; Huang YC; Wong LF; Hung MC; Tsai JC; Lee JM Lasers Med Sci; 2015 Dec; 30(9):2353-61. PubMed ID: 26450615 [TBL] [Abstract][Full Text] [Related]
20. Potentiation of the anti-tumour effects of Photofrin-based photodynamic therapy by localized treatment with G-CSF. Gołab J; Wilczyński G; Zagozdzon R; Stokłosa T; Dabrowska A; Rybczyńska J; Wasik M; Machaj E; Ołda T; Kozar K; Kamiński R; Giermasz A; Czajka A; Lasek W; Feleszko W; Jakóbisiak M Br J Cancer; 2000 Apr; 82(8):1485-91. PubMed ID: 10780531 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]